Evotec (ADR) (EVO)
Combines discovery, development and biologics manufacturing for pharmaceutical and biotechnology partners.
$1.58
After hours+0.01 (+0.64%)
At close$1.57(+1.95%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 44 days
EPS estimate
−$0.31
Revenue estimate
$167.2M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Apr '25May '25Aug '25Nov '25Apr '26May '26Aug '26Nov '26
Reported−$0.12−$0.15−$0.14−$0.14$0.05−$0.46−$0.17Pending
Estimate$0.02−$0.11−$0.18−$0.14$0.21−$0.15−$0.05−$0.31
Surprise−768.2%−37.1%+19.9%−1.4%−74.0%−209.5%−275.4%—
RevenueReportedEstimate
Apr '25May '25Aug '25Nov '25Apr '26May '26Aug '26Nov '26
Reported$229.1M$288.6M$201.6M$192.0M$347.6M$213.6M$166.7MPending
Estimate$205.3M$245.7M$191.8M$239.9M$328.8M$204.4M$174.6M$167.2M
Surprise+11.6%+17.5%+5.1%−20.0%+5.7%+4.5%−4.5%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.03 | — | — |
| Sep 2027 | $0.02 | — | — |
| Jun 2027 | $0.01 | — | — |
| Mar 2027 | $0.02 | — | — |
| Dec 2026 | −$0.12 | — | — |
| Nov 2026 | −$0.31 | — | — |
| Aug 2026 | −$0.05 | −$0.17 | −275.4% |
| May 2026 | −$0.15 | −$0.46 | −209.5% |
| Apr 2026 | $0.21 | $0.05 | −74.0% |
| Nov 2025 | −$0.14 | −$0.14 | −1.4% |
| Aug 2025 | |||
| May 2025 | |||
| Apr 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Dec 2021 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Dec 2019 | |||
| Mar 2020 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| Mar 2017 | |||
| May 2017 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.03 | — | — | $191.5M | — | — | — |
| Sep 2027 | $0.02 | — | — | $182.6M | — | — | — |
| Jun 2027 | $0.01 | — | — | $179.0M | — | — | — |
| Mar 2027 | $0.02 | — | — | $175.3M | — | — | — |
| Dec 2026 | −$0.12 | — | — | $171.8M | — | — | — |
| Nov 5, 2026 | −$0.31 | — | — | $167.2M | — | — | — |
| Aug 13, 2026 | −$0.05 | −$0.17 | −275.4% | $174.6M | $166.7M | −4.5% | −7.8% |
| May 6, 2026 | −$0.15 | −$0.46 | −209.5% | $204.4M | $213.6M | +4.5% | +1.3% |
| Apr 8, 2026 | $0.21 | $0.05 | −74.0% | $328.8M | $347.6M | +5.7% | −2.6% |
| Nov 5, 2025 | −$0.14 | −$0.14 | −1.4% | $239.9M | $192.0M | −20.0% | −15.6% |
| Aug 13, 2025 | |||||||
| May 6, 2025 | |||||||
| Apr 17, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 22, 2024 | |||||||
| Feb 26, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 29, 2023 | |||||||
| May 12, 2023 | |||||||
| Mar 29, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 11, 2022 | |||||||
| Dec 30, 2021 | |||||||
| Nov 10, 2021 | |||||||
| Aug 11, 2021 | |||||||
| May 11, 2021 | |||||||
| Mar 25, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 12, 2020 | |||||||
| May 14, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Mar 26, 2020 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Mar 28, 2019 | |||||||
| Nov 13, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 9, 2018 | |||||||
| Mar 28, 2018 | |||||||
| Nov 8, 2017 | |||||||
| Aug 10, 2017 | |||||||
| Mar 31, 2017 | |||||||
| May 10, 2017 | |||||||
| Sep 30, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Sep 30, 2015 | |||||||
| Jun 30, 2015 |